Search Clinical Trials
585,889 trials
ID
Status
Phase
Title
Sponsor
NCT07604961
Short-Term Inspiratory Muscle Training and Aerobic Exercise in Women With COPDMehmet İsmail TOSUNCompletedNot Applicable
NCT07604961Completed
Not Applicable
Short-Term Inspiratory Muscle Training and Aerobic Exercise in Women With COPDMehmet İsmail TOSUN
NCT07603037
EIT Evaluation of Different Antihypertensive Agents on the Ventilation-Perfusion Ratio in Patients With Acute Respiratory FailureFirst Affiliated Hospital of Wannan Medical CollegeNot Yet RecruitingNot Applicable
NCT07603037Not Yet Recruiting
Not Applicable
EIT Evaluation of Different Antihypertensive Agents on the Ventilation-Perfusion...First Affiliated Hospital...
NCT07604766
An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in ChinaGenmabNot Yet RecruitingPhase 3
NCT07604766Not Yet Recruiting
Phase 3
An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Inv...Genmab
NCT07604415
Active Versus Passive Anal Sphincter Training in Patients With Fecal IncontinenceComenius UniversityRecruitingNot Applicable
NCT07604415Recruiting
Not Applicable
Active Versus Passive Anal Sphincter Training in Patients With Fecal Incontinenc...Comenius University
NCT07601737
Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell CarcinomaShanghai General Hospital, Shanghai Jiao Tong University School of MedicineRecruitingPhase 2
NCT07601737Recruiting
Phase 2
Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of L...Shanghai General Hospital...
NCT07601997
Safety and Feasibility of Transcatheter Injectable Hydrogel in Acute STEMI Reperfusion Injury (REFINE Study)Myomed Technology (Shaoxing) Co., Ltd.Not Yet RecruitingNot Applicable
NCT07601997Not Yet Recruiting
Not Applicable
Safety and Feasibility of Transcatheter Injectable Hydrogel in Acute STEMI Reper...Myomed Technology (Shaoxi...
NCT07602049
Cryoablation Plus Camrelizumab for Advanced Soft Tissue SarcomaSun Yat-sen UniversityRecruitingPhase 2
NCT07602049Recruiting
Phase 2
Cryoablation Plus Camrelizumab for Advanced Soft Tissue SarcomaSun Yat-sen University
NCT07602426
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of resO™ Bone and Joint Support Postbiotic on Physical Function, Pain Interference, and Mobility in Adults With Joint DiscomfortAble Biolabs, LLCActive Not RecruitingNot Applicable
NCT07602426Active Not Recruiting
Not Applicable
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of...Able Biolabs, LLC
NCT07603856
A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung CancerUniversity of ChicagoNot Yet RecruitingPhase 2
NCT07603856Not Yet Recruiting
Phase 2
A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Sma...University of Chicago
NCT07604454
Muscle Energy Technique Combined With Mulligan Technique in Tennis ElbowUniversity of LahoreCompletedNot Applicable
NCT07604454Completed
Not Applicable
Muscle Energy Technique Combined With Mulligan Technique in Tennis ElbowUniversity of Lahore
NCT07600827
Isokinetic Training With Blood Flow Restriction for Patellofemoral Pain SyndromeGuilin institute of information technologyRecruitingNot Applicable
NCT07600827Recruiting
Not Applicable
Isokinetic Training With Blood Flow Restriction for Patellofemoral Pain SyndromeGuilin institute of infor...
NCT07602010
Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer StagingOslo University HospitalRecruiting
NCT07602010Recruiting
—
Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer StagingOslo University Hospital
NCT07600866
Validation of a Body-Composition Segmentation Software on a Diverse Public CT Scan CohortNucleo Research, Inc.Not Yet Recruiting
NCT07600866Not Yet Recruiting
—
Validation of a Body-Composition Segmentation Software on a Diverse Public CT Sc...Nucleo Research, Inc.
NCT07605234
Phase II Single Arm Open Label Study Evaluating the Feasibility and Safety of Photobiomodulation as an Adjunct to Standard Supportive Care for Chemotherapy Induced Oral Mucositis in Pediatric Patients With Hematolymphoid MalignanciesTata Memorial HospitalNot Yet RecruitingNot Applicable
NCT07605234Not Yet Recruiting
Not Applicable
Phase II Single Arm Open Label Study Evaluating the Feasibility and Safety of Ph...Tata Memorial Hospital
NCT07601048
A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard TreatmentShandong Suncadia Medicine Co., Ltd.Not Yet RecruitingPhase 3
NCT07601048Not Yet Recruiting
Phase 3
A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patient...Shandong Suncadia Medicin...
NCT07602699
Multi-Site Trial of Tirzepatide for Smoking CessationNational Institute on Drug Abuse (NIDA)RecruitingPhase 2
NCT07602699Recruiting
Phase 2
Multi-Site Trial of Tirzepatide for Smoking CessationNational Institute on Dru...
NCT07604623
Recurrent Laryngeal Nerve Monitoring During Pediatric Aerodigestive Tract and Cardiac SurgeryUniversity of AlbertaNot Yet RecruitingNot Applicable
NCT07604623Not Yet Recruiting
Not Applicable
Recurrent Laryngeal Nerve Monitoring During Pediatric Aerodigestive Tract and Ca...University of Alberta
NCT07604272
Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Inguinal Hernias in MalesNorthwestern UniversityNot Yet RecruitingPhase 1
NCT07604272Not Yet Recruiting
Phase 1
Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Ingui...Northwestern University
NCT07601269
Replacement of the Native Mitral Valve Using the ReValve SystemReValve Solutions Inc.RecruitingEarly Phase 1
NCT07601269Recruiting
Early Phase 1
Replacement of the Native Mitral Valve Using the ReValve SystemReValve Solutions Inc.
Result Breakdown
Not yet recruiting9 (45%)
Recruiting7 (35%)
Completed3 (15%)
Active, not recruiting1 (5%)
not_applicable9 (45%)
Phase 24 (20%)
Not Specified3 (15%)
Phase 32 (10%)
Phase 11 (5%)
Early Phase 11 (5%)